RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-22 4:17 pm Sale | 2024-10-18 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,443,181 19.990% | -299,812 (-2.79%) | Filing |
| 2024-09-16 9:35 pm Purchase | 2024-09-12 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,742,993 19.990% | 149,598 (+1.41%) | Filing |
| 2024-03-06 6:54 pm Purchase | 2024-03-04 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,593,395 19.990% | 1,922,751 (+22.18%) | Filing |
| 2021-06-16 5:20 pm Purchase | 2021-06-15 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 8,670,644 20.800% | 8,670,644 (New Position) | Filing |